HOFFMAN WILLIAM (President and CEO) sold 12.0% of their position (60K shares) of INARI MEDICAL, INC. on the open market
Open‑market sale worth $3.34M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
−3.18K
Price / share
$54.33
Trade value
$172.55K
% of position
Common Stock
Shares
−20.92K
Price / share
$55.23
Trade value
$1.16M
% of position
Common Stock
Shares
−13.56K
Price / share
$56.45
Trade value
$765.46K
% of position
Common Stock
Shares
−2.35K
Price / share
$56.82
Trade value
$133.36K
% of position
Common Stock
Shares
−2.10K
Price / share
$54.42
Trade value
$114.28K
% of position
Common Stock
Shares
−10.30K
Price / share
$55.27
Trade value
$569.34K
% of position
Common Stock
Shares
−7.47K
Price / share
$56.51
Trade value
$421.96K
% of position
Common Stock
Shares
−132.00
Price / share
$56.89
Trade value
$7.51K
% of position
Net shares
−60K
Net value
-$3.34M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/16/2024 | S · Sale | −3.18K | $54.33 | $172.55K | 0.6% | 501.23K | 498.06K |
| Common Stock Direct | 12/16/2024 | S · Sale | −20.92K | $55.23 | $1.16M | 4.2% | 498.06K | 477.14K |
| Common Stock Direct | 12/16/2024 | S · Sale | −13.56K | $56.45 | $765.46K | 2.8% | 477.14K | 463.58K |
| Common Stock Direct | 12/16/2024 | S · Sale | −2.35K | $56.82 | $133.36K | 0.5% | 463.58K | 461.23K |
| Common Stock Direct | 12/16/2024 | S · Sale | −2.10K | $54.42 | $114.28K | 0.5% | 461.23K | 459.13K |
| Common Stock Direct | 12/16/2024 | S · Sale | −10.30K | $55.27 | $569.34K | 2.2% | 459.13K | 448.83K |
| Common Stock Direct | 12/16/2024 | S · Sale | −7.47K | $56.51 | $421.96K | 1.7% | 448.83K | 441.37K |
| Common Stock Direct | 12/16/2024 | S · Sale | −132.00 | $56.89 | $7.51K | 0.0% | 441.37K | 441.23K |
| Total | −60K | -$3.34M | ||||||